Clinical trial
Pharmacokinetics and Safety of Treatment With Paracetamol in Children and Adults With Spinal Muscular Atrophy and Cerebral Palsy
NCT03648658 is registered in ClinicalTrials.gov with Mette Cathrine Oerngreen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics and Safety of Treatment With Paracetamol in Children and Adults With Spinal Muscular Atrophy and Cerebral Palsy
- Lead sponsor
- Mette Cathrine Oerngreen
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 18, 2019
- Completion date
- December 31, 2024
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral palsy, sma ii